Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Kerala Ayurveda Limited receives US patent for its herbal formulation - The Pharma Times | Pharma & Health Care News Portal
Approval

Kerala Ayurveda Limited receives US patent for its herbal formulation

  • The United States Patent and Trademark Office (USPTO) has granted KAL its first patent for a proprietary herbal formulation that is uniquely processed and inspired by ancient ayurvedic wisdom
  • The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders such as type 2 diabetes mellitus, obesity, and lipid profile management

Bengaluru, December 10, 2022: Kerala Ayurveda Limited (KAL) announced at the 9th World Ayurveda Congress and Arogya Expo 2022 Inaugurated in Goathat it has received its first patent from The United States Patent and Trademark Office (USPTO) for a proprietary herbal formulation that is uniquely processed and inspired by ancient ayurvedic wisdom.

A statistical framework was conducted on the formulation using the rigors of modern scientific validation, including Phytochemical & Marker Analysis, extensive pre-clinical testing at Renovel Discoveries Inc.in the United States, and a pharma rigor double-blind placebo-controlled clinical study at the well-known Banaras Hindu University (BHU) in India.

The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders such as type 2 diabetes mellitus, obesity, and lipid profile management, as well as its use in the preparation of food supplements, pharmaceuticals, and nutraceuticals in appropriate dosage forms such as beverages/liquids, capsules, tablets, granules, jellies, to mention a few.

Dr. JayarajanKodikannath, CEO of Kerala Ayurveda USA, said, “With a perfect profile demonstrated by our team, this milestone will now allow Kerala Ayurveda to play a significant role in the global Ayurvedic. This patent supports our commitment to treat diseases driven by managing metabolic syndrome disorders such as type 2 diabetes mellitus, obesity, and lipid profile management. Ayurveda is on the cusp of making a mega movement as its sister science, yoga, became mainstream in the west.”

He adds, “There is a massive shift in the human psyche from the chemical-oriented and reductive approach to natural holistic consciousness-based living. We see that Post COVID, this shift to a more natural preventative and self-care approach, became much more relevant. Kerala Ayurveda Academy USA has been focusing on creating confident and capable Ayurvedic professionals across the globe to serve the communities through providing authentic teachings of Kerala’s traditional practices.”

Ramesh Vangal, Chairman of Kerala Ayurveda Limited, said, “Kerala Ayurveda has a sweeping global vision for Ayurveda. To do this, we have had to establish international scientific validation of our safe, pure, and effective products. Our recent acquisition of a US patent on metabolic disorders for Kerala Ayurveda is a significant breakthrough. Together with our large vocational institution in the United States, its 3000 practitioners, and 200 products specially made for the USA, we will spearhead a global movement. Our range of high-quality products meets California Prop 65 standards (CA Prop 65) which are the most stringent in the world. ”

With this invention, KAL’s main goal was to establish Safety, Purity, and Efficacy, as well as to provide a standardised process for preparing such an herbal composition, resulting in a standardized product with specifications that could indicate batch-to-batch consistency (in terms of particular specific active ingredient composition that are unique to the herbal blend and are believed to contribute to the efficacy of the formulations so prepared and developed).

For more information visit us at www.keralaayurveda.biz

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

19 hours ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

2 days ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

5 days ago

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

1 week ago

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

2 weeks ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

2 weeks ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420